Use of the Perclose ProGlide suture-mediated closure strategy to achieve vascular access-site hemostasis after transfemoral TAVR results in fewer major vascular complications than does deployment of ...
LAS VEGAS, NV—Vascular closure complications occur in about one-quarter of patients undergoing transfemoral TAVR, according to post hoc analysis of the BRAVO 3 trial, but not all closure devices ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. LAS VEGAS — In a comparison of two vascular closure ...
LAS VEGAS -- Bleeding complication risk after transcatheter aortic valve replacement (TAVR) isn't the same between two of the most commonly used femoral vascular closure devices, one study showed, ...
Please provide your email address to receive an email when new articles are posted on . During elective transcatheter aortic valve replacement, use of a double Prostar XL suture-based closure ...
Results from an analysis of a large randomized trial shows ProGlide vascular closure device (VCD) was associated with lower rates of vascular complications, lower rates of acute kidney injury (AKI) ...
LAS VEGAS (MAY 21, 2019) - Results from an analysis of a large randomized trial shows ProGlide vascular closure device (VCD) was associated with lower rates of vascular complications, lower rates of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback